Edition:
United Kingdom

Diplomat Pharmacy Inc (DPLO.N)

DPLO.N on New York Stock Exchange

27.66USD
20 Jun 2018
Change (% chg)

$0.75 (+2.79%)
Prev Close
$26.91
Open
$27.18
Day's High
$27.66
Day's Low
$27.13
Volume
11,047
Avg. Vol
189,571
52-wk High
$27.73
52-wk Low
$14.24

Select another date:

Mon, Feb 26 2018

BRIEF-Diplomat Pharmacy Posts Q4 Adj. Earnings Per Share $0.18

* DIPLOMAT ANNOUNCES 4TH QUARTER AND 2017 YEAR END FINANCIAL RESULTS; PROVIDES 2018 GUIDANCE

BRIEF-Diplomat Pharmacy Says Dispensing Advanced Kidney Treatment, CABOMETYX

* DIPLOMAT PHARMACY INC - ‍IS DISPENSING EXELIXIS' LIMITED-DISTRIBUTION TREATMENT CABOMETYX NOW WITH AN EXPANDED INDICATION​ Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

BRIEF-Diplomat Reaffirms 2017 Guidance And Provides Preliminary 2018 Outlook

* DIPLOMAT PHARMACY INC - ‍JEFF PARK, HAS BEEN APPOINTED INTERIM CHIEF EXECUTIVE OFFICER, EFFECTIVE IMMEDIATELY​

BRIEF-Diplomat Reaffirms 2017 Guidance, Provides Preliminary 2018 Outlook

* - EXPECTS 2017 REVENUE TO BE NEAR MIDDLE OF PREVIOUSLY PROVIDED RANGE

BRIEF-Diplomat Completes Acquisition Of LDI Integrated Pharmacy Services

* DIPLOMAT COMPLETES ACQUISITION OF LDI INTEGRATED PHARMACY SERVICES, SECURES NEW CREDIT FACILITIES

Select another date: